A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian Federation

A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

NCT02615184 ·Status: TERMINATED ·Phase: PHASE2

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

NCT00627016 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis

NCT00321737 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients

NCT02873689 ·Status: COMPLETED ·Phase: PHASE3

Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease

NCT02351960 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis

NCT00255164 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

NCT00251693 ·Status: COMPLETED ·Phase: PHASE3

A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old

NCT02616302 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents

NCT01642602 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

NCT00251719 ·Status: COMPLETED ·Phase: PHASE3

Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain

NCT01637571 ·Status: WITHDRAWN ·Phase: PHASE4

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents

NCT01642615 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis

NCT02873702 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of DLBS2411 in the Management of GERD

NCT03367195 ·Status: TERMINATED ·Phase: PHASE3

Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)

NCT00911534 ·Status: COMPLETED ·Phase: PHASE3

The Effects of Dexlansoprazole for the Treatment of Throat-Related Reflux

NCT01317472 ·Status: TERMINATED ·Phase: NA

Response to Supplement and Placebo in GERD

NCT01915173 ·Status: COMPLETED ·Phase: NA

Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months

NCT02442752 ·Status: WITHDRAWN ·Phase: PHASE1

A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks

NCT03591653 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis

NCT04531475 ·Status: COMPLETED ·Phase: PHASE2

Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study

NCT00963144 ·Status: COMPLETED

ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)

NCT00820079 ·Status: COMPLETED ·Phase: PHASE2

A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital Practice

NCT07004439 ·Status: NOT_YET_RECRUITING ·Phase: NA

Dexlansoprazole MR in Nonerosive Reflux Disease

NCT02490449 ·Status: UNKNOWN ·Phase: NA

Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity

NCT00884247 ·Status: COMPLETED